Tiziana Life Sciences (TLSA) Other Non-Current Assets (2018 - 2020)
Tiziana Life Sciences (TLSA) posted quarterly Other Non-Current Assets of $269447.9 for Q2 2020, down 3.47% year-on-year from $279129.8 in Q3 2019, and down 3.42% on a QoQ basis from $279002.3 in Q4 2019.
Tiziana Life Sciences (TLSA) Other Non-Current Assets (2018 - 2020) Analysis & Trends
Tiziana Life Sciences (TLSA) has reported Other Non-Current Assets for 3 consecutive years, with $269447.9 the latest figure, recorded in Q2 2020.
- Quarterly Other Non-Current Assets fell 3.47% year-over-year to $269447.9 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $269447.9 (down 3.47% YoY) and the FY2019 annual result came in at $285000.0, down 1.66% from the prior year.
- Other Non-Current Assets slipped to $269447.9 in Q2 2020 per TLSA's latest filing, from $279002.3 in the prior quarter.
- Over the last five years, Other Non-Current Assets for TLSA reached as high as $295631.0 in Q2 2018 and fell as low as $269447.9 in Q2 2020.
- A 3-year average of $280487.9 and a median of $279129.8 in 2019 frame the typical range for Other Non-Current Assets.
- The largest YoY upside for Other Non-Current Assets was 0.08% in 2019 against a maximum downside of 5.58% in 2019.
- Year by year, Other Non-Current Assets stood at $279228.5 in 2018, then fell by 0.08% to $279002.3 in 2019, then slipped by 3.42% to $269447.9 in 2020.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $269447.9, $279002.3, and $279129.8 for Q2 2020, Q4 2019, and Q2 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 14.48 Mn |
| 10 | Tiziana Life Sciences | 109.20 Mn | 105.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 269,447.94 |
| Dec 31, 2019 | 279,002.30 |
| Jun 30, 2019 | 279,129.84 |
| Dec 31, 2018 | 279,228.49 |
| Jun 30, 2018 | 295,631.00 |